Evidence map›Paper›PMID 15554924›Full record

ArticleImmunology2004

Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes.

Tatiana Lebedeva, Nadja Anikeeva, Spyros A Kalams, Bruce D Walker, Ibragim Gaidarov, James H Keen, Yuri Sykulev

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Homotypic and heterotypicCurrent research in immunology · 2022
    Review
  4. Open MHC Class I Conformers: A Look through the Looking Glass.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Immunosuppressive drug therapy.Cold Spring Harbor perspectives in medicine · 2013
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tatiana LebedevaDepartment of Microbiology and Immunology and Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Nadja Anikeeva
Spyros A Kalams
Bruce D Walker
Ibragim Gaidarov
James H Keen
Yuri Sykulev
Thomas Jefferson University · USHarvard University · US

Funding

TCR GENE USAGE AND QUANTITATION OF HIV SPECIFIC CTLR01AI039966 · NIAID · VANDERBILT UNIVERSITY · PI KALAMS, SPYROS A · 1997 to 2006
$3.2M
TRAINING PROGRAMS IN CANCER IMMUNOLOGYT32CA009683 · NCI · THOMAS JEFFERSON UNIVERSITY · PI EISENLOHR, LAURENCE CRANE · 1993 to 2007
$1.5M
CLATHRIN AND MEMBRANE FUNCTIONR01GM028526 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI KEEN, JAMES H · 1985 to 2004
$1.2M
NRSA TRAINING PROGRAM FOR AIDS RESEARCHT32AI007523 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SRINIVASAN, ALAGARSAMY · 1997 to 2001
$303k
NCI NIH HHS 5-T32-CA09683NCI NIH HHS T32 CA009683NIAID NIH HHS 5-T32-AI07523NIAID NIH HHS AI3254NIAID NIH HHS AI39966NIAID NIH HHS R01 AI039966NIAID NIH HHS T32 AI007523NIGMS NIH HHS GM-28526NIGMS NIH HHS R01 GM028526
6 · The paper itself

Abstract

Polarization and segregation of the T-cell receptor (TCR) and integrins upon productive cytotoxic T-lymphocyte (CTL) target cell encounters are well documented. Much less is known about the redistribution of major histocompatibility complex class I (MHC-I) and intercellular adhesion molecule-1 (ICAM-1) proteins on target cells interacting with CTLs. Here we show that human leucocyte antigen-A2 (HLA-A2) MHC-I and ICAM-1 are physically associated and recovered from both the raft fraction and the fraction of soluble membranes of target cells. Conjugation of target cells with surrogate CTLs, i.e. polystyrene beads loaded with antibodies specific for HLA-A2 and ICAM-1, induced the accumulation of membrane rafts, and beads loaded with ICAM-1-specific antibodies caused the selective recruitment of HLA-A2 MHC-I at the contact area of the target cells. Disruption of raft integrity on target cells led to a release of HLA-A2 and ICAM-1 from the raft fraction, abatement of HLA-A2 polarization, and diminished the ability of target cells bearing viral peptides to induce a Ca(2+) flux in virus-specific CTLs. These data suggest that productive engagement of ICAM-1 on target cells facilitates the polarization of MHC-I at the CTL-target cell interface, augmenting presentation of cognate peptide-MHC (pMHC) complexes to CTLs. We propose that ICAM-1-MHC-I association on the cell membrane is a mechanism that enhances the linkage between antigen recognition and early immunological synapse formation.

Indexed as

Antigen PresentationAntigens, Viralbeta-CyclodextrinsCalciumCell MembraneEnzyme InhibitorsHLA-A2 AntigenHumansIntercellular Adhesion Molecule-1Membrane Microdomainssrc-Family KinasesT-Lymphocytes, CytotoxicAntigens, Viralbeta-CyclodextrinsCalciumEnzyme InhibitorsHLA-A2 AntigenIntercellular Adhesion Molecule-1methyl-beta-cyclodextrinsrc-Family Kinases

Identifiers

PMID15554924
PMCPMC1782605
OpenAlexW2072404428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.